Please enter your username below and press the send button.A password reset link will be sent to you.
If you are unable to access the email address originally associated with your Delicious account, we recommend creating a new account.
This link recently saved by napwa on February 20, 2014
This link recently saved by napwa on September 17, 2013
Blood levels of MK-1439, a next-generation HIV non-nucleoside reverse transcriptase inhibitors (NNRTI) in phase 2b trials, rose significantly when combined with ritonavir, but tenofovir had little effect, researchers reported at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Denver.
This link recently saved by napwa on April 18, 2013
This link recently saved by napwa on July 17, 2012
This link recently saved by napwa on May 22, 2012
This link recently saved by napwa on March 07, 2012
This link recently saved by napwa on March 01, 2012
Health care providers are being reminded not to prescribe certain cholesterol-reducing medications—notably members of the “statin” drug class—for people living with hepatitis C virus (HCV) using either Incivek (telaprevir) or Victrelis (boceprevir), according to a recent U.S. Food and Drug Administration (FDA)safety announcement.
This link recently saved by napwa on February 16, 2012
An international Hep C activist group is calling on government regulators and pharmaceutical companies developing therapies for hepatitis C virus (HCV) infection to conduct necessary interaction studies involving other medications commonly used by people living with HCV and HIV/HCV coinfection as early as possible.
This link recently saved by napwa on February 09, 2012
Merck & Co's recently approved Victrelis treatment for hepatitis C considerably lessens the effectiveness of some widely used medicines against the virus that causes AIDS, Merck and U.S. regulators said in separate reports.
This link recently saved by napwa on January 08, 2012
New guidelines from the American Academy of Neurology (AAN) and the International League Against Epilepsy (ILAE) have been published online ahead of print by the journal Neurology to help people living with HIV and their care providers choose seizure drugs that do not interact negatively with antiretrovirals (ARVs).